| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/08/2006 | CA2097063C Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 08/03/2006 | WO2006080821A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080505A1 Hair growing tonic, hair growing tonic composition and method of hair growth and restoration |
| 08/03/2006 | WO2006080398A1 Composition for preparing carbon dioxide preparation for external use |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006079830A1 Alkoxylated lanolin derivatives and compositions therewith |
| 08/03/2006 | WO2006079568A2 Use of 3-sulfanylpropanamide derivatives for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof |
| 08/03/2006 | WO2006079563A1 Adapalene for the long-term treatment of acne vulgaris |
| 08/03/2006 | WO2006079288A1 Use of human lysozyme for preparing cosmetics against acne |
| 08/03/2006 | WO2006079176A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | WO2006057932A3 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 08/03/2006 | WO2006050734A3 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 08/03/2006 | WO2006000339A3 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 08/03/2006 | WO2005110452A3 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFα-RELATED DISORDERS |
| 08/03/2006 | US20060173076 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060173072 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173028 Therapeutic and/or preventive agent for chronic skin disease |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173007 Compounds, compositions, and methods |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172955 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172298 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | DE60117606T2 Orale zusammensetzungen zur behandlung von kopfhauterkrankungen Oral compositions for treatment of scalp disorders |
| 08/03/2006 | CA2596537A1 Molecules and chimeric molecules thereof |
| 08/03/2006 | CA2591062A1 Adapalene for the long-term treatment of acne vulgaris |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1685876A1 Solid cosmetic cleansing composition |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685823A1 Cosmetic composition |
| 08/02/2006 | EP1684780A1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 08/02/2006 | EP1684779A1 Method for controlling angiogenesis in animals |
| 08/02/2006 | EP1684768A2 Methods of treating eczema |
| 08/02/2006 | EP1684760A1 Method and composition for treatment of cutaneous lesions |
| 08/02/2006 | EP1684737A1 Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 08/02/2006 | EP1214051B1 Use of a vegetable oil product as agent for increasing skin lipid synthesis |
| 08/02/2006 | EP1212328B1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 08/02/2006 | EP1210341B1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 08/02/2006 | EP1163274B1 Process for cross-linking hyaluronic acid to polymers |
| 08/02/2006 | EP1120108B1 Skin care preparations for external use |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |
| 08/02/2006 | CN2801159Y Powder medicine patch packaged by immediate dissolution film |
| 08/02/2006 | CN1812798A Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas |
| 08/02/2006 | CN1812795A Composition for external use |
| 08/02/2006 | CN1812784A New use i |
| 08/02/2006 | CN1812763A Nail restructuring compositions for topical application |
| 08/02/2006 | CN1810822A 2-aminocarbonyl-9h-purine derivatives |
| 08/02/2006 | CN1810777A Compound for preventing and treating bacterial infection and its prepn and use |
| 08/02/2006 | CN1810286A Externally applied plaster |
| 08/02/2006 | CN1810280A Medicine composition for treating rheumatism, rheumatoidal diseases, etc. and its prepn process |
| 08/02/2006 | CN1810272A Prepn process of red sage prepn and its quality control method |
| 08/02/2006 | CN1810261A Composition for eliminating irritation on skin and prepn of synergistic skin protecting film |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/02/2006 | CN1267432C 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267151C Alkaline fibroblast growth factor pellicle and its production method |
| 08/02/2006 | CN1267146C Psoriasis-treating composition |
| 08/02/2006 | CN1267119C Medication for curing skin disease |
| 08/02/2006 | CN1267105C Broad spectrum bacteriostat and sterilizing of silicate based angstrom silver ion nano porous composite mateiral |
| 08/02/2006 | CN1267104C Medicine for preventing and treating chilblain and its preparation method |
| 08/02/2006 | CN1267085C Modifying the fatty acid composition of cell membranes of organs and tissues |
| 08/01/2006 | US7084262 Analysis and separation of platelet-derived growth factor proteins |
| 08/01/2006 | US7084176 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 08/01/2006 | US7084172 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084159 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 08/01/2006 | US7084147 Anilinoquinazaolines as protein tyrosine kinase inhibitors |
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 08/01/2006 | US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7083957 Modified proteins, designer toxins, and methods of making thereof |
| 08/01/2006 | US7083820 Dehydration and stabilization of naturally occurring substance containing biologically active components, e.g. proteins, by heating with a microbiocide at a temperature below denaturization; food processing; drugs; cosmetics |
| 08/01/2006 | US7083799 No-synthase inhibitors |
| 08/01/2006 | CA2234611C New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/27/2006 | WO2006078117A1 Composition for improving hair growth comprising an non-polar solvent-soluble extract of cantharis as an active ingredient |
| 07/27/2006 | WO2006078067A1 Age production inhibitor, use of the same, and process for production of the same |
| 07/27/2006 | WO2006077407A2 Modulators of itch ubiquitinase activity |
| 07/27/2006 | WO2006077168A1 Pyrazolopyridines, their preparation and their medical use |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167064 Pharmaceutical liquid composition containing pyridone derivative |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |